🔎 Trials Near Me

Domov › Skleroderma › Florida

Klinične študije za Skleroderma v Florida

9 študij za Skleroderma išče udeležence na lokacijah v Florida.

Mesta v Florida

Uradno besedilo študije (angleško)

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  • Millennium Research - Ormond Beach, Ormond Beach
  • Integral Rheumatology and Immunology Specialist, Plantation
  • BioResearch Partner - South Miami, South Miami
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07497087

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

  • IRIS Research and Development LLC, Plantation
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06655155

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Mayo Clinic, Jacksonville
Vključevanje udeležencevFaza 1
Starost 18–74 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Jacksonville
  • GSK Investigational Site, Miami
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT05878717

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Mayo Clinic Florida, Jacksonville
Vključevanje udeležencevFaza 2/3
Starost 18–75 · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

  • Nkarta Investigational Site, Gainesville
  • Nkarta Investigational Site, Plantation
Vključevanje udeležencevFaza 1/2
Starost 18–75 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Jupiter, Jupiter
  • Artiva Investigational Site Miami, Miami
  • Artiva Investigational Site Plantation, Plantation
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT06991114

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • University of Florida, Gainesville
  • Nicklaus Children's Hospital, Miami
Vključevanje udeležencevFaza 1
Starost 12–70 · Vsi spoli · Posodobljeno 22. maj 2026 · NCT06308978

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Miami
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 7. maj 2025 · NCT05892614

Vir: ClinicalTrials.gov, podatki pridobljeni 4. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.